Literature DB >> 20124204

Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex.

J Y Wu1, N Salamon, H E Kirsch, M M Mantle, S S Nagarajan, L Kurelowech, M H Aung, R Sankar, W D Shields, G W Mathern.   

Abstract

BACKGROUND: The unambiguous identification of the epileptogenic tubers in individuals with tuberous sclerosis complex (TSC) can be challenging. We assessed whether magnetic source imaging (MSI) and coregistration of (18)fluorodeoxyglucose PET (FDG-PET) with MRI could improve the identification of the epileptogenic regions noninvasively in children with TSC.
METHODS: In addition to standard presurgical evaluation, 28 children with intractable epilepsy from TSC referred from 2000 to 2007 had MSI and FDG-PET/MRI coregistration without extraoperative intracranial EEG.
RESULTS: Based on the concordance of test results, 18 patients with TSC (64%) underwent surgical resection, with the final resection zone confirmed by intraoperative electrocorticography. Twelve patients are seizure free postoperatively (67%), with an average follow-up of 4.1 years. Younger age at surgery and shorter seizure duration were associated with postoperative seizure freedom. Conversely, older age and longer seizure duration were linked with continued seizures postoperatively or prevented surgery because of nonlateralizing or bilateral independent epileptogenic zones. Complete removal of presurgery MSI dipole clusters correlated with postoperative seizure freedom.
CONCLUSIONS: Magnetic source imaging and (18)fluorodeoxyglucose PET/MRI coregistration noninvasively localized the epileptogenic zones in many children with intractable epilepsy from tuberous sclerosis complex (TSC), with 67% seizure free postoperatively. Seizure freedom after surgery correlated with younger age and shorter seizure duration. These findings support the concept that early epilepsy surgery is associated with seizure freedom in children with TSC and intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124204      PMCID: PMC2816007          DOI: 10.1212/WNL.0b013e3181ce5d9e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Neural networks in human epilepsy: evidence of and implications for treatment.

Authors:  Susan S Spencer
Journal:  Epilepsia       Date:  2002-03       Impact factor: 5.864

2.  Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex.

Authors:  J Y Wu; W W Sutherling; S Koh; N Salamon; R Jonas; S Yudovin; R Sankar; W D Shields; G W Mathern
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

3.  Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: a prospective study.

Authors:  Robert C Knowlton; Rotem Elgavish; Jennifer Howell; Jeffery Blount; Jorge G Burneo; Edward Faught; Pongkiat Kankirawatana; Kristen Riley; Richard Morawetz; Julie Worthington; Ruben I Kuzniecky
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

4.  Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome.

Authors:  S Koh; P Jayakar; C Dunoyer; S E Whiting; T J Resnick; L A Alvarez; G Morrison; J Ragheb; A Prats; P Dean; J Gilman; M S Duchowny
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

Review 5.  Varieties of human secondary epileptogenesis.

Authors:  F Morrell
Journal:  J Clin Neurophysiol       Date:  1989-07       Impact factor: 2.177

6.  Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach.

Authors:  Howard L Weiner; Chad Carlson; Emily B Ridgway; Charles M Zaroff; Daniel Miles; Josiane LaJoie; Orrin Devinsky
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

Review 7.  Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex.

Authors:  M Karenfort; B Kruse; H Freitag; H Pannek; I Tuxhorn
Journal:  Neuropediatrics       Date:  2002-10       Impact factor: 1.947

8.  Epilepsy surgery in tuberous sclerosis complex: early predictive elements and outcome.

Authors:  F Teutonico; R Mai; O Devinsky; G Lo Russo; H L Weiner; P Borrelli; U Balottin; P Veggiotti
Journal:  Childs Nerv Syst       Date:  2008-08-14       Impact factor: 1.475

9.  Secondary epileptogenesis in man.

Authors:  F Morrell
Journal:  Arch Neurol       Date:  1985-04

10.  Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients.

Authors:  M M Guerreiro; F Andermann; E Andermann; A Palmini; P Hwang; H J Hoffman; H Otsubo; A Bastos; F Dubeau; G J Snipes; A Olivier; T Rasmussen
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

View more
  20 in total

1.  Removing interictal fast ripples on electrocorticography linked with seizure freedom in children.

Authors:  J Y Wu; R Sankar; J T Lerner; J H Matsumoto; H V Vinters; G W Mathern
Journal:  Neurology       Date:  2010-10-06       Impact factor: 9.910

Review 2.  α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.

Authors:  Ajay Kumar; Eishi Asano; Harry T Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

3.  [Chinese expert consensus on surgical treatment of tuberous sclerosis complex-related epilepsy].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

4.  Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration.

Authors:  Marian E Williams; Deborah A Pearson; Jamie K Capal; Anna W Byars; Donna S Murray; Robin Kissinger; Sarah E O'Kelley; Ellen Hanson; Nicole M Bing; Bridget Kent; Joyce Y Wu; Hope Northrup; E Martina Bebin; Mustafa Sahin; Darcy Krueger
Journal:  Am Psychol       Date:  2019-04

Review 5.  Neurosurgical treatment of tuberous sclerosis complex lesions.

Authors:  Ignacio Pascual-Castroviejo
Journal:  Childs Nerv Syst       Date:  2011-05-24       Impact factor: 1.475

6.  Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II.

Authors:  Carlos Cepeda; Véronique M André; Irene Yamazaki; Jason S Hauptman; Jane Y Chen; Harry V Vinters; Gary W Mathern; Michael S Levine
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

Review 7.  Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.

Authors:  Emma van der Poest Clement; Floor E Jansen; Kees P J Braun; Jurriaan M Peters
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

8.  α-[11C]-Methyl-L-tryptophan--PET in 191 patients with tuberous sclerosis complex.

Authors:  Harry T Chugani; Aimee F Luat; Ajay Kumar; Rajkumar Govindan; Kathy Pawlik; Eishi Asano
Journal:  Neurology       Date:  2013-07-12       Impact factor: 9.910

9.  Long-term outcomes of epilepsy surgery in tuberous sclerosis complex.

Authors:  Shuli Liang; Juncheng Zhang; Zhixian Yang; Shaohui Zhang; Zhiqiang Cui; Jianfei Cui; Jiwu Zhang; Na Liu; Ping Ding
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

10.  Sociodemographic changes over 25 years of pediatric epilepsy surgery at UCLA.

Authors:  Jason S Hauptman; Andrew Dadour; Taemin Oh; Christine B Baca; Barbara G Vickrey; Stefanie D Vassar; Raman Sankar; Noriko Salamon; Harry V Vinters; Gary W Mathern
Journal:  J Neurosurg Pediatr       Date:  2013-01-18       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.